We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
-4.42%
1 Year Est. Return
+128.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8M
AUM Growth
-$92.3M
Cap. Flow
-$95.3M
Cap. Flow %
-418.11%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$65.7M
2
KYMR icon
Kymera Therapeutics
KYMR
+$29.5M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$14.6M 63.94%
223,486
-824,071
-79% -$65.7M
RLYB icon
2
Rallybio
RLYB
$85.8M
$4.14M 18.18%
94,335
KYMR icon
3
Kymera Therapeutics
KYMR
$8.94B
$1.53M 6.71%
19,648
-437,411
-96% -$29.5M
SEER icon
4
Seer Inc
SEER
$120M
$1.49M 6.56%
816,375
XLO icon
5
Xilio Therapeutics
XLO
$60.3M
$427K 1.88%
47,696
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$421K 1.85%
12,437
STRO icon
7
Sutro Biopharma
STRO
$421M
$202K 0.89%
17,500

Similar funds

AJU IB Investment Company's Q4 2025 Portfolio in Review

As of Q4 2025, AJU IB Investment Company held 7 positions worth $22.8M, down 80% from $115M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AJU IB Investment Company withdrew a net $95.3M in Q4 2025, reducing 2 holdings. Its largest reduction was Arcellx, cutting an estimated $65.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AJU IB Investment Company's biggest Q4 2025 reduction was Arcellx, cutting an estimated $65.7M.
  • AJU IB Investment Company's ten largest holdings make up 100% of its $22.8M portfolio in Q4 2025.
  • AJU IB Investment Company opened 0 new positions and closed 0 in Q4 2025.
  • AJU IB Investment Company's portfolio value fell 80% quarter-over-quarter to $22.8M.

Based on AJU IB Investment Company's 13F filing for Q4 2025, filed 10 Feb 2026.